Life without brain serotonin: Reevaluation of serotonin function with mice deficient in brain serotonin synthesis

Behavioural Brain Research

Volumn 277, Issue , 2015, Pages 78-88

  Mosienko, Valentina ^a   Beis, Daniel ^a   Pasqualetti, Massimo ^b   Waider, Jonas ^c   Matthes, Susann ^a   Qadri, Fatimunnisa ^a   Bader, Michael ^a   Alenina, Natalia ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Animal model; Behavior; Serotonin; Serotonin receptors; Serotonin transporter; Tryptophan hydroxylase 2

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 4 AMINOBUTYRIC ACID; 5 HYDROXYINDOLEACETIC ACID; DOPAMINE; GLUTAMIC ACID; HOMOVANILLIC ACID; NORADRENALIN; NORMETADRENALIN; SEROTONIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN HYDROXYLASE 2; TRYPTOPHAN HYDROXYLASE;

AGGRESSION; ANXIETY; ATTENTION DEFICIT DISORDER; AUTISM; AVERSIVE BEHAVIOR; BLOOD PRESSURE REGULATION; DEPRESSION; DOPAMINERGIC SYSTEM; DORSAL RAPHE NUCLEUS; GABAERGIC SYSTEM; GROWTH RETARDATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LIPID STORAGE; NEGLECT; NONHUMAN; NORADRENERGIC SYSTEM; POSTNATAL DEVELOPMENT; RESPIRATION CONTROL; REVIEW; SEROTONIN BRAIN LEVEL; SEROTONIN METABOLISM; SEROTONIN SYNDROME; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION; THERMOREGULATION; WEIGHT REDUCTION; ANIMAL; ANIMAL BEHAVIOR; BRAIN; DEFICIENCY; DISEASE MODEL; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; HUMANS; RECEPTORS, SEROTONIN; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

EID: 84912066548     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.06.005     Document Type: Review

References (99)

1. Henry D.P., Bowsher R.R. An improved radioenzymatic assay for plasma norepinephrine using purified phenylethanolamine N-methyltransferase. Life Sci 1986, 38(16):1473-1483.
2. Juorio A.V., Boulton A.A. The effect of some precursor amino acids and enzyme inhibitors on the mouse striatal concentration of tyramines and homovanillic acid. J Neurochem 1982, 39(3):859-863.
3. Dyck L.E. Release of some endogenous trace amines from rat striatal slices in the presence and absence of a monoamine oxidase inhibitor. Life Sci 1989, 44(17):1149-1156.
4. Fitzpatrick P.F. Tetrahydropterin-dependent amino acid hydroxylases. Annu Rev Biochem 1999, 68:355-381.
5. Veenstra-VanderWeele J., Anderson G.M., Cook E.H. Pharmacogenetics and the serotonin system: initial studies and future directions. Eur J Pharmacol 2000, 410(2-3):165-181.
6. Kim K.S., Wessel T.C., Stone D.M., Carver C.H., Joh T.H., Park D.H. Molecular cloning and characterization of cDNA encoding tryptophan hydroxylase from rat central serotonergic neurons. Brain Res Mol Brain Res 1991, 9(4):277-283.
7. Walther D.J., Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 2003, 66(9):1673-1680.
8. Walther D.J., Peter J.U., Bashammakh S., Hortnagl H., Voits M., Fink H., et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science (New York, NY) 2003, 299(5603):76.
9. Cote F., Fligny C., Bayard E., Launay J.M., Gershon M.D., Mallet J., et al. Maternal serotonin is crucial for murine embryonic development. Proc Nat Acad Sci USA 2007, 104(1):329-334.
10. Gutknecht L., Kriegebaum C., Waider J., Schmitt A., Lesch K.P. Spatio-temporal expression of tryptophan hydroxylase isoforms in murine and human brain: convergent data from Tph2 knockout mice. Eur Neuropsychopharmacol 2009, 19(4):266-282.
11. Yadav V.K., Oury F., Suda N., Liu Z.W., Gao X.B., Confavreux C., et al. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 2009, 138(5):976-989.
12. Patel P.D., Pontrello C., Burke S. Robust and tissue-specific expression of TPH2 versus TPH1 in rat raphe and pineal gland. Biol Psychiatry 2004, 55(4):428-433.
13. Sakowski S.A., Geddes T.J., Thomas D.M., Levi E., Hatfield J.S., Kuhn D.M. Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies. Brain Res 2006, 1085(1):11-18.
14. Zill P., Buttner A., Eisenmenger W., Moller H.J., Ackenheil M., Bondy B. Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: a post-mortem study. J Psychiatr Res 2007, 41(1-2):168-173.
15. Gershon M.D. Serotonin is a sword and a shield of the bowel: serotonin plays offense and defense. Trans Am Clin Climatol Assoc 2012, 123:268-280. (Discussion 280).
16. Clark J.A., Alves S., Gundlah C., Rocha B., Birzin E.T., Cai S.J., et al. Selective estrogen receptor-beta (SERM-beta) compounds modulate raphe nuclei tryptophan hydroxylase-1 (TPH-1) mRNA expression and cause antidepressant-like effects in the forced swim test. Neuropharmacology 2012, 63(6):1051-1063.
17. Gundlah C., Alves S.E., Clark J.A., Pai L.Y., Schaeffer J.M., Rohrer S.P. Estrogen receptor-beta regulates tryptophan hydroxylase-1 expression in the murine midbrain raphe. Biol Psychiatry 2005, 57(8):938-942.
18. Malek Z.S., Dardente H., Pevet P., Raison S. Tissue-specific expression of tryptophan hydroxylase mRNAs in the rat midbrain: anatomical evidence and daily profiles. Eur J Neurosci 2005, 22(4):895-901.
19. Nakamura K., Sugawara Y., Sawabe K., Ohashi A., Tsurui H., Xiu Y., et al. Late developmental stage-specific role of tryptophan hydroxylase 1 in brain serotonin levels. J Neurosci 2006, 26(2):530-534.
20. Migliarini S., Pacini G., Pelosi B., Lunardi G., Pasqualetti M. Lack of brain serotonin affects postnatal development and serotonergic neuronal circuitry formation. Mol Psychiatry 2013, 18(10):1106-1118.
21. Kriegebaum C., Song N.N., Gutknecht L., Huang Y., Schmitt A., Reif A., et al. Brain-specific conditional and time-specific inducible Tph2 knockout mice possess normal serotonergic gene expression in the absence of serotonin during adult life. Neurochem Int 2010, 57(5):512-517.
22. Alenina N., Kikic D., Todiras M., Mosienko V., Qadri F., Plehm R., et al. Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc Nat Acad Sci USA 2009, 106(25):10332-10337.
23. Angoa-Perez M., Kane M.J., Briggs D.I., Sykes C.E., Shah M.M., Francescutti D.M., et al. Genetic depletion of brain 5HT reveals a common molecular pathway mediating compulsivity and impulsivity. J Neurochem 2012, 121(6):974-984.
24. Gutknecht L., Waider J., Kraft S., Kriegebaum C., Holtmann B., Reif A., et al. Deficiency of brain 5-HT synthesis but serotonergic neuron formation in Tph2 knockout mice. J Neural Transm 2008, 115(8):1127-1132.
25. Liu Y., Jiang Y., Si Y., Kim J.Y., Chen Z.F., Rao Y. Molecular regulation of sexual preference revealed by genetic studies of 5-HT in the brains of male mice. Nature 2011, 472(7341):95-99.
26. Liu Z., Zhou J., Li Y., Hu F., Lu Y., Ma M., et al. Dorsal raphe neurons signal reward through 5-HT and glutamate. Neuron 2014, 81(6):1360-1374.
27. Savelieva K.V., Zhao S., Pogorelov V.M., Rajan I., Yang Q., Cullinan E., et al. Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants. PLoS One 2008, 3(10):e3301.
28. Wu Q., Clark M.S., Palmiter R.D. Deciphering a neuronal circuit that mediates appetite. Nature 2012, 483(7391):594-597.
29. Parks C.L., Robinson P.S., Sibille E., Shenk T., Toth M. Increased anxiety of mice lacking the serotonin1A receptor. Proc Nat Acad Sci USA 1998, 95(18):10734-10739.
30. Mosienko V., Bert B., Beis D., Matthes S., Fink H., Bader M., et al. Exaggerated aggression and decreased anxiety in mice deficient in brain serotonin. Transl Psychiatry 2012, 2:e122.
31. Gutknecht L., Araragi N., Merker S., Waider J., Sommerlandt F.M., Mlinar B., et al. Impacts of brain serotonin deficiency following Tph2 inactivation on development and Raphe neuron serotonergic specification. PLoS One 2012, 7(8):e43157.
32. Araragi N., Mlinar B., Baccini G., Gutknecht L., Lesch K.P., Corradetti R. Conservation of 5-HT1A receptor-mediated autoinhibition of serotonin (5-HT) neurons in mice with altered 5-HT homeostasis. Front Pharmacol 2013, 4:97.
33. Zhang S., Liu Y., Rao Y. Serotonin signaling in the brain of adult female mice is required for sexual preference. Proc Nat Acad Sci USA 2013, 110(24):9968-9973.
34. Haberzettl R., Bert B., Fink H., Fox M.A. Animal models of the serotonin syndrome: a systematic review. Behav Brain Res 2013, 256:328-345.
35. Fox M.A., Jensen C.L., French H.T., Stein A.R., Huang S.J., Tolliver T.J., et al. Neurochemical, behavioral, and physiological effects of pharmacologically enhanced serotonin levels in serotonin transporter (SERT)-deficient mice. Psychopharmacology (Berl) 2008, 201(2):203-218.
36. Sanacora G., Mason G.F., Rothman D.L., Krystal J.H. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 2002, 159(4):663-665.
37. Nazar M., Siemiatkowski M., Czlonkowska A., Sienkiewicz-Jarosz H., Plaznik A. The role of the hippocampus and 5-HT/GABA interaction in the central effects of benzodiazepine receptor ligands. J Neural Transm 1999, 106(5-6):369-381.
38. Nemmani K.V., Mogil J.S. Serotonin-GABA interactions in the modulation of mu- and kappa-opioid analgesia. Neuropharmacology 2003, 44(3):304-310.
39. Allers K.A., Sharp T. Neurochemical and anatomical identification of fast- and slow-firing neurones in the rat dorsal raphe nucleus using juxtacellular labelling methods in vivo. Neuroscience 2003, 122(1):193-204.
40. Calizo L.H., Akanwa A., Ma X., Pan Y.Z., Lemos J.C., Craige C., et al. Raphe serotonin neurons are not homogenous: electrophysiological, morphological and neurochemical evidence. Neuropharmacology 2011, 61(3):524-543.
41. Day H.E., Greenwood B.N., Hammack S.E., Watkins L.R., Fleshner M., Maier S.F., et al. Differential expression of 5HT-1A, alpha 1b adrenergic, CRF-R1, and CRF-R2 receptor mRNA in serotonergic, gamma-aminobutyric acidergic, and catecholaminergic cells of the rat dorsal raphe nucleus. J Comp Neurol 2004, 474(3):364-378.
42. Kiss J., Csaki A., Bokor H., Kocsis K., Kocsis B. Possible glutamatergic/aspartatergic projections to the supramammillary nucleus and their origins in the rat studied by selective [(3)H]d-aspartate labelling and immunocytochemistry. Neuroscience 2002, 111(3):671-691.
43. Kohler C., Steinbusch H. Identification of serotonin and non-serotonin-containing neurons of the mid-brain raphe projecting to the entorhinal area and the hippocampal formation. A combined immunohistochemical and fluorescent retrograde tracing study in the rat brain. Neuroscience 1982, 7(4):951-975.
44. Li A.H., Wang H.L. G protein-coupled receptor kinase 2 mediates mu-opioid receptor desensitization in GABAergic neurons of the nucleus raphe magnus. J Neurochem 2001, 77(2):435-444.
45. Bagdy E., Kiraly I., Harsing L.G. Reciprocal innervation between serotonergic and GABAergic neurons in raphe nuclei of the rat. Neurochem Res 2000, 25(11):1465-1473.
46. Monti J.M., Jantos H., Lagos P. Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat. Behav Brain Res 2010, 206(1):8-16.
47. Nishikawa T., Scatton B. Evidence for a GABAergic inhibitory influence on serotonergic neurons originating from the dorsal raphe. Brain Res 1983, 279(1-2):325-329.
48. Scatton B., Zivkovic B., Dedek J., Lloyd K.G., Constantinidis J., Tissot R., et al. gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas. J Pharmacol Exp Ther 1982, 220(3):678-688.
49. Shen R.Y., Andrade R. 5-Hydroxytryptamine2 receptor facilitates GABAergic neurotransmission in rat hippocampus. J Pharmacol Exp Ther 1998, 285(2):805-812.
50. Abi-Saab W.M., Bubser M., Roth R.H., Deutch A.Y. 5-HT2 receptor regulation of extracellular GABA levels in the prefrontal cortex. Neuropsychopharmacology 1999, 20(1):92-96.
51. Boothman L., Raley J., Denk F., Hirani E., Sharp T. In vivo evidence that 5-HT(2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. Br J Pharmacol 2006, 149(7):861-869.
52. Liu R., Jolas T., Aghajanian G. Serotonin 5-HT(2) receptors activate local GABA inhibitory inputs to serotonergic neurons of the dorsal raphe nucleus. Brain Res 2000, 873(1):34-45.
53. Varga V., Losonczy A., Zemelman B.V., Borhegyi Z., Nyiri G., Domonkos A., et al. Fast synaptic subcortical control of hippocampal circuits. Science (New York, NY) 2009, 326(5951):449-453.
54. Nikolaus S., Antke C., Beu M., Muller H.W. Cortical GABA, striatal dopamine and midbrain serotonin as the key players in compulsive and anxiety disorders-results from in vivo imaging studies. Rev Neurosci 2010, 21(2):119-139.
55. Petit-Demouliere B., Masse F., Cogrel N., Hascoet M., Bourin M. Brain structures implicated in the four-plate test in naive and experienced Swiss mice using injection of diazepam and the 5-HT2A agonist DOI. Behav Brain Res 2009, 204(1):200-205.
56. Bonnin A., Torii M., Wang L., Rakic P., Levitt P. Serotonin modulates the response of embryonic thalamocortical axons to netrin-1. Nat Neurosci 2007, 10(5):588-597.
57. Di Pino G., Moessner R., Lesch P., Lauder J., Persico A. Roles for serotonin in neurodevelopment: more than just neural transmission. Curr Neuropharmacol 2004, 2:403-418.
58. Gaspar P., Cases O., Maroteaux L. The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 2003, 4(12):1002-1012.
59. Vitalis T., Cases O., Passemard S., Callebert J., Parnavelas J.G. Embryonic depletion of serotonin affects cortical development. Eur J Neurosci 2007, 26(2):331-344.
60. Riccio O., Potter G., Walzer C., Vallet P., Szabo G., Vutskits L., et al. Excess of serotonin affects embryonic interneuron migration through activation of the serotonin receptor 6. Mol Psychiatry 2009, 14(3):280-290.
61. Waider J., Proft F., Langlhofer G., Asan E., Lesch K.P., Gutknecht L. GABA concentration and GABAergic neuron populations in limbic areas are differentially altered by brain serotonin deficiency in Tph2 knockout mice. Histochem Cell Biol 2013, 139(2):267-281.
62. Gulyas A.I., Acsady L., Freund T.F. Structural basis of the cholinergic and serotonergic modulation of GABAergic neurons in the hippocampus. Neurochem Int 1999, 34(5):359-372.
63. Puig M.V., Gulledge A.T. Serotonin and prefrontal cortex function: neurons, networks, and circuits. Mol Neurobiol 2011, 44(3):449-464.
64. Atack J.R. Subtype-selective GABA(A) receptor modulation yields a novel pharmacological profile: the design and development of TPA023. Adv Pharmacol 2009, 57:137-185.
65. Mohler H., Fritschy J.M., Rudolph U. A new benzodiazepine pharmacology. J Pharmacol Exp Ther 2002, 300(1):2-8.
66. Gordon J.A., Hen R. Genetic approaches to the study of anxiety. Annu Rev Neurosci 2004, 27:193-222.
67. Low K., Crestani F., Keist R., Benke D., Brunig I., Benson J.A., et al. Molecular and neuronal substrate for the selective attenuation of anxiety. Science (New York, NY) 2000, 290(5489):131-134.
68. Rudolph U., Crestani F., Benke D., Brunig I., Benson J.A., Fritschy J.M., et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 1999, 401(6755):796-800.
69. Wiltgen B.J., Sanders M.J., Ferguson C., Homanics G.E., Fanselow M.S. Trace fear conditioning is enhanced in mice lacking the delta subunit of the GABAA receptor. Learn Mem (Cold Spring Harbor, NY) 2005, 12(3):327-333.
70. Engin E., Liu J., Rudolph U. Alpha2-containing GABA(A) receptors: a target for the development of novel treatment strategies for CNS disorders. Pharmacol Ther 2012, 136(2):142-152.
71. Beis D., Mosienko V., Bader M., Alenina N. Interactions of serotonin and diazepam on behavioral inhibition in tryptophan hydroxylase 2 deficient mice. Program nr. 302.17, 2011 Neuroscience Meeting Planner 2011, Society for Neuroscience, Washington, (Online).
72. Handbook of Behavioral Neurobiology of Serotonin Handbook of behavioral neurobiology of serotonin 2010, Elsevier, Amsterdam.
73. Clemett D.A., Punhani T., Duxon M.S., Blackburn T.P., Fone K.C. Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS. Neuropharmacology 2000, 39(1):123-132.
74. Molineaux S.M., Jessell T.M., Axel R., Julius D. 5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system. Proc Nat Acad Sci USA 1989, 86(17):6793-6797.
75. Pompeiano M., Palacios J.M., Mengod G. Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res Mol Brain Res 1994, 23(1-2):163-178.
76. Sharma A., Punhani T., Fone K.C. Distribution of the 5-hydroxytryptamine2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody: effect of 5,7-dihydroxytryptamine. Synapse 1997, 27(1):45-56.
77. Wright D.E., Seroogy K.B., Lundgren K.H., Davis B.M., Jennes L. Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain. J Comp Neurol 1995, 351(3):357-373.
78. Auclair A.L., Cathala A., Sarrazin F., Depoortere R., Piazza P.V., Newman-Tancredi A., et al. The central serotonin 2B receptor: a new pharmacological target to modulate the mesoaccumbens dopaminergic pathway activity. J Neurochem 2010, 114(5):1323-1332.
79. Thomas D.M., Angoa Perez M., Francescutti-Verbeem D.M., Shah M.M., Kuhn D.M. The role of endogenous serotonin in methamphetamine-induced neurotoxicity to dopamine nerve endings of the striatum. J Neurochem 2010, 115(3):595-605.
80. Blakely R.D., De Felice L.J., Hartzell H.C. Molecular physiology of norepinephrine and serotonin transporters. J Exp Biol 1994, 196:263-281.
81. Bhattacharyya S., Raote I., Bhattacharya A., Miledi R., Panicker M.M. Activation, internalization, and recycling of the serotonin 2A receptor by dopamine. Proc Nat Acad Sci USA 2006, 103(41):15248-15253.
82. Raote I., Bhattacharyya S., Panicker M.M. Functional selectivity in serotonin receptor 2A (5-HT2A) endocytosis, recycling, and phosphorylation. Mol Pharmacol 2013, 83(1):42-50.
83. Narboux-Neme N., Angenard G., Mosienko V., Klempin F., Pitychoutis P.M., Deneris E., et al. Postnatal growth defects in mice with constitutive depletion of central serotonin. ACS Chem Neurosci 2013, 4(1):171-181.
84. Kane M.J., Angoa-Perez M., Briggs D.I., Sykes C.E., Francescutti D.M., Rosenberg D.R., et al. Mice genetically depleted of brain serotonin display social impairments, communication deficits and repetitive behaviors: possible relevance to autism. PLoS One 2012, 7(11):e48975.
85. Erickson J.T., Shafer G., Rossetti M.D., Wilson C.G., Deneris E.S. Arrest of 5HT neuron differentiation delays respiratory maturation and impairs neonatal homeostatic responses to environmental challenges. Respir Physiol Neurobiol 2007, 159(1):85-101.
86. Hickner S., Hussain N., Angoa-Perez M., Francescutti D.M., Kuhn D.M., Mateika J.H. Ventilatory long-term facilitation is evident after initial and repeated exposure to intermittent hypoxia in mice genetically depleted of brain serotonin. J Appl Physiol (1985) 2014, 116(3):240-250.
87. Hodges M.R., Tattersall G.J., Harris M.B., McEvoy S.D., Richerson D.N., Deneris E.S., et al. Defects in breathing and thermoregulation in mice with near-complete absence of central serotonin neurons. J Neurosci 2008, 28(10):2495-2505.
88. Brommage R., Smith D.D., Liu J., Yu W., Yang Q.M., Powell D.R. Genetic disruption of brain serotonin content in mice produces leanness with hyperphagia and elevated physical activity but minimal skeletal changes. Abstract Nr. SUN-94, 2012. ENDO meeting 2012, The Endocrine Society, Houston, TX, (Online).
89. Lam D.D., Leinninger G.M., Louis G.W., Garfield A.S., Marston O.J., Leshan R.L., et al. Leptin does not directly affect CNS serotonin neurons to influence appetite. Cell Metab 2011, 13(5):584-591.
90. Halford J.C., Harrold J.A., Boyland E.J., Lawton C.L., Blundell J.E. Serotonergic drugs: effects on appetite expression and use for the treatment of obesity. Drugs 2007, 67(1):27-55.
91. Fernandez S.P., Gaspar P. Investigating anxiety and depressive-like phenotypes in genetic mouse models of serotonin depletion. Neuropharmacology 2012, 62(1):144-154.
92. Lesch K.P., Araragi N., Waider J., van den Hove D., Gutknecht L. Targeting brain serotonin synthesis: insights into neurodevelopmental disorders with long-term outcomes related to negative emotionality, aggression and antisocial behaviour. Philos Trans R Soc Lond B: Biol Sci 2012, 367(1601):2426-2443.
93. Lesch K.P., Waider J. Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. Neuron 2012, 76(1):175-191.
94. Migliarini S., Pacini G., Pelosi B., Errico B., Lunardi G., Usiello A., Paqualetti M. Tryptophan hydroxylase 2 (Tph2) knockout mice reveal a critical role for brain serotonin (5-HT) in postnatal development and in adult behaviour. Program nr. 61.3, 2009 Neuroscience Meeting Planner 2009, Society for Neuroscience, Chicago, IL, (Online).
95. Lerch-Haner J.K., Frierson D., Crawford L.K., Beck S.G., Deneris E.S. Serotonergic transcriptional programming determines maternal behavior and offspring survival. Nat Neurosci 2008, 11(9):1001-1003.
96. Klempin F., Beis D., Mosienko V., Kempermann G., Bader M., Alenina N. Serotonin is required for exercise-induced adult hippocampal neurogenesis. J Neurosci 2013, 33(19):8270-8275.
97. Cryan J.F., Holmes A. The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discovery 2005, 4(9):775-790.
98. Cryan J.F., Mombereau C. In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 2004, 9(4):326-357.
99. Ray R.S., Corcoran A.E., Brust R.D., Kim J.C., Richerson G.B., Nattie E., et al. Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition. Science (New York, NY) 2011, 333(6042):637-642.